Cite

HARVARD Citation

    Kita, Y. et al. (2022). Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre‐enfortumab vedotin era. International journal of urology. pp. 647-655. [Online]. 
  
Back to record